Condensed Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses:
Research and development	$ 13,070,108	$ 1,766,227	$ 15,306,451	$ 3,613,641
General and administrative	573,360	447,714	1,128,787	911,113
Total operating expenses	13,643,468	2,213,941	16,435,238	4,524,754
Loss from operations	(13,643,468)	(2,213,941)	(16,435,238)	(4,524,754)
Other income (expense)
Interest expense	(391,187)	(31)	(391,210)	(64)
Interest income	1,803	11,983	2,191	75,834
Loss on sale of fixed assets	0	0	(263)	0
Other income (expense), net	(389,384)	11,952	(389,282)	75,770
Net loss before income taxes	(14,032,852)	(2,201,989)	(16,824,520)	(4,448,984)
Income tax benefits	0	0	0	0
Net loss	$ (14,032,852)	$ (2,201,989)	$ (16,824,520)	$ (4,448,984)
Net loss per share, basic and diluted	$ (1.11)	$ (0.21)	$ (1.42)	$ (0.43)
Weighted average common shares outstanding, basic and diluted	12,610,917	10,260,234	11,845,758	10,257,111